S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
Clinical trial NCT00041067 · COMPLETED
Trial details
- NCT number
- NCT00041067
- Sponsor
- SWOG Cancer Research Network
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2008-01-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.